WIL
ECYT

Winifred I. Li’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Winifred I. Li’s Portfolio ECYT Stock Details ECYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$10K Hold
1,590
– – 0.01% 413
2014
Q3 		$10K Hold
1,590
– – 0.01% 363
2014
Q2 		$10K Sell
1,590
-10
-0.6% -$113 0.01% 356
2014
Q1 		$38K Hold
1,600
– – 0.03% 314
2013
Q4 		$17K Hold
1,600
– – 0.01% 339
2013
Q3 		$21K Buy
+1,600
New +$25.3K 0.02% 333

Other funds holding ECYT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Winifred I. Li's ECYT Position: Q4 2014 in Review

Winifred I. Li held its Endocyte, Inc. Common Stock (ECYT) position steady in Q4 2014 at 1,590 shares worth $10K. The position accounts for 0.01% of the portfolio, ranked #413.

Winifred I. Li first reported a position in ECYT in Q3 2013 and has held it in 6 quarters since. The position peaked at $38K in Q1 2014. 100 funds tracked by Wall St. Rank hold ECYT as of Q4 2014.

  • Winifred I. Li held 1,590 shares of Endocyte, Inc. Common Stock worth $10K as of Q4 2014.
  • Winifred I. Li left its Endocyte, Inc. Common Stock share count unchanged in Q4 2014.
  • Endocyte, Inc. Common Stock made up 0.01% of Winifred I. Li's portfolio in Q4 2014, its #413 holding.
  • Winifred I. Li first reported a position in Endocyte, Inc. Common Stock in Q3 2013 and has held it in 6 quarters since.
  • Winifred I. Li's Endocyte, Inc. Common Stock position peaked at $38K in Q1 2014.
  • 100 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2014.

Based on Winifred I. Li's 13F filing for Q4 2014, filed 19 Feb 2015.